Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Nicol

Showing results (251-260 of 286) with videos related to

Pageof 29
Sort By:
The Lancet. Microbe|June 26, 2025
Centrifuge-free stool processing methods for Xpert MTB/RIF Ultra tuberculosis diagnosis in children in Uganda and Zambia: an observational, prospective, diagnostic accuracy studyManon Lounnas, Eden Ngu Masama, Samuel Beneteau, et al.
Plos Medicine|November 17, 2011
Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysisAnna Vassall, Sanne van Kampen, Hojoon Sohn, et al.
Journal of Clinical Microbiology|February 16, 2022
Whole-Genome Sequencing Has the Potential To Improve Treatment for Rifampicin-Resistant Tuberculosis in High-Burden Settings: a Retrospective Cohort StudyHelen Cox, Galo A Goig, Zubeida Salaam-Dreyer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 29, 2014
Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adultsLydia Nakiyingi, Vineshree Mischka Moodley, Yukari C Manabe, et al.
The Lancet. Global Health|July 19, 2015
Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIFGavin J Churchyard, Wendy S Stevens, Lerole D Mametja, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2025
Nasopharyngeal microbiota in South African infants with lower respiratory tract infection: a nested case-control study of the Drakenstein Child Health StudyShantelle Claassen-Weitz, Yao Xia, Luke Hannan, et al.
The Lancet. Microbe|November 12, 2021
Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology studyHelen Cox, Zubeida Salaam-Dreyer, Galo A Goig, et al.
JAMA Network Open|December 17, 2020
Effect of Once-Weekly Azithromycin vs Placebo in Children With HIV-Associated Chronic Lung Disease: The BREATHE Randomized Clinical TrialRashida A Ferrand, Grace McHugh, Andrea M Rehman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2020
Cost-effectiveness of a Novel Lipoarabinomannan Test for Tuberculosis in Patients With Human Immunodeficiency VirusKrishna P Reddy, Claudia M Denkinger, Tobias Broger, et al.
The Lancet. Infectious Diseases|June 4, 2019
Novel lipoarabinomannan point-of-care tuberculosis test for people with HIV: a diagnostic accuracy studyTobias Broger, Bianca Sossen, Elloise du Toit, et al.
Pageof 29

Showing results (251-260 of 286) with videos related to

Sort By:
Pageof 29
The Lancet. Microbe|June 26, 2025
Centrifuge-free stool processing methods for Xpert MTB/RIF Ultra tuberculosis diagnosis in children in Uganda and Zambia: an observational, prospective, diagnostic accuracy studyManon Lounnas, Eden Ngu Masama, Samuel Beneteau, et al.
Plos Medicine|November 17, 2011
Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysisAnna Vassall, Sanne van Kampen, Hojoon Sohn, et al.
Journal of Clinical Microbiology|February 16, 2022
Whole-Genome Sequencing Has the Potential To Improve Treatment for Rifampicin-Resistant Tuberculosis in High-Burden Settings: a Retrospective Cohort StudyHelen Cox, Galo A Goig, Zubeida Salaam-Dreyer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 29, 2014
Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adultsLydia Nakiyingi, Vineshree Mischka Moodley, Yukari C Manabe, et al.
The Lancet. Global Health|July 19, 2015
Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIFGavin J Churchyard, Wendy S Stevens, Lerole D Mametja, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2025
Nasopharyngeal microbiota in South African infants with lower respiratory tract infection: a nested case-control study of the Drakenstein Child Health StudyShantelle Claassen-Weitz, Yao Xia, Luke Hannan, et al.
The Lancet. Microbe|November 12, 2021
Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology studyHelen Cox, Zubeida Salaam-Dreyer, Galo A Goig, et al.
JAMA Network Open|December 17, 2020
Effect of Once-Weekly Azithromycin vs Placebo in Children With HIV-Associated Chronic Lung Disease: The BREATHE Randomized Clinical TrialRashida A Ferrand, Grace McHugh, Andrea M Rehman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2020
Cost-effectiveness of a Novel Lipoarabinomannan Test for Tuberculosis in Patients With Human Immunodeficiency VirusKrishna P Reddy, Claudia M Denkinger, Tobias Broger, et al.
The Lancet. Infectious Diseases|June 4, 2019
Novel lipoarabinomannan point-of-care tuberculosis test for people with HIV: a diagnostic accuracy studyTobias Broger, Bianca Sossen, Elloise du Toit, et al.
Pageof 29